Department of Microbiology and Immunology, Liver Research Institute and Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea.
PLoS One. 2012;7(10):e47372. doi: 10.1371/journal.pone.0047372. Epub 2012 Oct 10.
Previous studies have proved the presence of several distinct types of mutations in hepatitis B virus (HBV) infections, which are related to the progression of liver disease. However, few reports have detailed the mutation frequencies and mutation patterns in the precore/core (preC/C) region, which are based on the clinical status and HBeAg serostatus. Our aim in this study is to investigate the relationships between the preC/C mutations and clinical severity or HBeAg serostatus from patients chronically infected with HBV genotype C. A total of 70 Korean chronic patients, including 35 with hepatocellular carcinoma (HCC), participated in this study. HBV genotyping and precore/core mutations were analyzed by direct sequencing. All patients were confirmed to have genotype C infections. Mutations in the C region were distributed in a non-random manner. In particular, mutations in the MHC class II restricted region were found to be significantly related to HCC. Six (preC-W28*, C-P5H/L/T, C-E83D, C-I97F/L, C-L100I and C-Q182K/) and seven types (preC-W28, preC-G29D, C-D32N/H, C-E43K, C-P50A/H/Y, C-A131G/N/P and C-S181H/P) of mutations in the preC/C region were found to be related to HCC and to affect the HBeAg serostatus, respectively. In conclusion, our data indicated that HBV variants in the C region, particularly in the MHC class II restricted region, may contribute to the progress of HCC in chronic patients infected with genotype C. In addition, we found several distinct preC/C mutations in the Korean chronic cohort, which affect the clinical status of HCC and HBeAg serostatus of patients infected with genotype C.
先前的研究已经证明,乙型肝炎病毒(HBV)感染中存在几种不同类型的突变,这些突变与肝病的进展有关。然而,很少有报道详细描述基于临床状况和 HBeAg 血清状态的前核心/核心(preC/C)区域中的突变频率和突变模式。我们的研究目的是调查慢性 C 基因型 HBV 感染患者中 preC/C 突变与临床严重程度或 HBeAg 血清状态之间的关系。共有 70 名韩国慢性患者参与了本研究,其中 35 名患有肝细胞癌(HCC)。通过直接测序分析 HBV 基因分型和 preC/C 突变。所有患者均被确认为感染基因型 C。C 区的突变呈非随机分布。特别是,MHC 类 II 受限区域的突变与 HCC 显著相关。六种(preC-W28*、C-P5H/L/T、C-E83D、C-I97F/L、C-L100I 和 C-Q182K/)和七种类型(preC-W28、preC-G29D、C-D32N/H、C-E43K、C-P50A/H/Y、C-A131G/N/P 和 C-S181H/P)的 preC/C 区域突变与 HCC 相关,并分别影响 HBeAg 血清状态。总之,我们的数据表明,C 区的 HBV 变异体,特别是 MHC 类 II 受限区域的变异体,可能导致慢性感染 C 基因型的患者 HCC 的进展。此外,我们在韩国慢性队列中发现了几种不同的 preC/C 突变,这些突变影响了感染 C 基因型的 HCC 患者的临床状态和 HBeAg 血清状态。